Bydenaf Trademark Details

This mark is alive with a status of Second Extension - Granted. The last case file activity for this mark occured 7 years ago on Wednesday, September 14, 2016, according to the United State Patent & Trademark Office
Word Mark Bydenaf
Status Alive 731 — Second Extension - Granted

Current Owner

Raptor Pharmaceuticals Inc. of Novato, CA

View all trademarks for Raptor Pharmaceuticals Inc.
Other Trademarks for Raptor Pharmaceuticals Inc.
Serial Number 86508416
Status Date Wednesday, September 14, 2016
Filing Date Wednesday, September 14, 2016
Attorney Richard M. LaBarge

Correspondent

RICHARD M. LABARGE
Marshall Gerstein Borun
233 S Wacker Dr Ste 6300
Chicago, IL 60606-6471

Case File Statements

Goods & Services Pharmaceutical preparations for treating genetic disorders; pharmaceutical preparations for treating neurological disorders; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating Huntington's disease and related disorders; pharmaceutical preparations for treating fibrotic disorders; pharmaceutical preparations for treating mitochondrial disease; and pharmaceutical preparations for treating NAFLD and NASH disease and related disorders

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Saturday, January 31, 2015
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.